Patents by Inventor Philip N. Bryan

Philip N. Bryan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160053248
    Abstract: The present invention provides a new method for engineering or evolving enzymes to have desirable characteristics. Among the desirable characteristics is the ability to control catalytic activity through the use of a trigger molecule that rescues a catalytic site defect introduced during the engineering process. The method includes co-evolving enzyme and substrate to retain or improve substrate binding activity in the absence of catalytic activity.
    Type: Application
    Filed: September 10, 2015
    Publication date: February 25, 2016
    Inventor: Philip N. Bryan
  • Publication number: 20120270241
    Abstract: The present invention provides a new method for engineering or evolving enzymes to have desirable characteristics. Among the desirable characteristics is the ability to control catalytic activity through the use of a trigger molecule that rescues a catalytic site defect introduced during the engineering process. The method includes co-evolving enzyme and substrate to retain or improve substrate binding activity in the absence of catalytic activity.
    Type: Application
    Filed: September 23, 2010
    Publication date: October 25, 2012
    Inventor: Philip N. Bryan
  • Patent number: 8241885
    Abstract: The present invention is directed to the identification of a protease prodomain that is capable of binding a corresponding protease with high affinity. The protease prodomain of the present invention is fused to a second protein to form a protease prodomain fusion protein. The presence of a protease prodomain protein in a fusion protein allows for easy and selective purification of the second protein by incubation with the corresponding protease.
    Type: Grant
    Filed: September 22, 2010
    Date of Patent: August 14, 2012
    Assignee: University of Maryland, College Park
    Inventor: Philip N. Bryan
  • Publication number: 20110008869
    Abstract: The present invention is directed to the identification of a protease prodomain that is capable of binding a corresponding protease with high affinity. The protease prodomain of the present invention is fused to a second protein to form a protease prodomain fusion protein. The presence of a protease prodomain protein in a fusion protein allows for easy and selective purification of the second protein by incubation with the corresponding protease.
    Type: Application
    Filed: September 22, 2010
    Publication date: January 13, 2011
    Applicant: UNIVERSITY OF MARYLAND COLLEGE PARK
    Inventor: Philip N. Bryan
  • Patent number: 7824885
    Abstract: The present invention is directed to the identification of a protease prodomain that is capable of binding a corresponding protease with high affinity. The protease prodomain of the present invention is fused to a second protein to form a protease prodomain fusion protein. The presence of a protease prodomain protein in a fusion protein allows for easy and selective purification of the second protein by incubation with the corresponding protease.
    Type: Grant
    Filed: June 29, 2004
    Date of Patent: November 2, 2010
    Assignee: University of Maryland, College Park
    Inventor: Philip N. Bryan
  • Patent number: 6541234
    Abstract: Novel calcium free subtilisin mutants are taught, in particular subtilisins which have been mutated to eliminate amino acids 75-83 and which retain enzymatic activity and stability. Recombinant methods for producing same and recombinant DNA encoding for such subtilisin mutants are also provided.
    Type: Grant
    Filed: September 11, 2000
    Date of Patent: April 1, 2003
    Assignee: University of Maryland Biotechnology Institute
    Inventor: Philip N. Bryan
  • Patent number: 6541235
    Abstract: Novel calcium free subtilisin mutants are taught, in particular subtilisins which have been mutated to eliminate amino acids 75-83 and part or all of amino acids 1-22 (the N-terminal region) and which retain enzymatic activity and stability. Recombinant methods for producing the same and recombinant DNA encoding for such subtilisin mutants are also provided.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: April 1, 2003
    Assignee: University of Maryland Biotechnology Institute
    Inventor: Philip N. Bryan
  • Patent number: 5707848
    Abstract: Novel calcium free subtilisin mutants are taught, in particular a subtilisin which has been mutated to eliminate amino acids 75-83.
    Type: Grant
    Filed: November 27, 1995
    Date of Patent: January 13, 1998
    Assignee: University of Maryland
    Inventors: Philip N. Bryan, Patrick A. Alexander, Susan L. Strausberg
  • Patent number: 5567601
    Abstract: Novel calcium free subtilisin mutants are taught, in particular subtilisins which have been mutated to eliminate amino acids 75-83 and which retain enzymatic activity and stability. Recombinant methods for producing same and recombinant DNA encoding for such subtilisin mutants are also provided.
    Type: Grant
    Filed: September 20, 1994
    Date of Patent: October 22, 1996
    Assignee: University of Maryland
    Inventors: Philip N. Bryan, Patrick A. Alexander, Susan L. Strausberg
  • Patent number: 5470733
    Abstract: Novel calcium free subtilisin mutants are taught, in particular a subtilisin which has been mutated to eliminate amino acids 75-83.
    Type: Grant
    Filed: June 1, 1993
    Date of Patent: November 28, 1995
    Assignee: University of Maryland
    Inventors: Philip N. Bryan, Patrick A. Alexander, Susan L. Strausberg
  • Patent number: 5260207
    Abstract: The present invention provides a method for redesigning proteins to increase the stability of the protein by altering amino acid residue(s) that are in close proximity to the protein's metal ion binding site(s). Further, the invention is directed to proteins that have been redesigned to have enhanced stability according to the methods of this invention.
    Type: Grant
    Filed: October 19, 1990
    Date of Patent: November 9, 1993
    Assignee: Enzon Labs Inc.
    Inventors: Michael W. Pantoliano, Barry C. Finzel, Philip N. Bryan
  • Patent number: 5246849
    Abstract: The invention relates to subtilisin enzymes which have been modified by mutating a nucleotide sequence (gene) coding for the subtilisin. The modified subtilisin enzymes have enhanced thermal stability.
    Type: Grant
    Filed: March 19, 1991
    Date of Patent: September 21, 1993
    Assignee: Enzon, Inc.
    Inventors: Philip N. Bryan, Michael W. Pantoliano
  • Patent number: 5116741
    Abstract: The invention relates to the novel use of mutants of subtilisin in organic syntheses reactions in non-native environments. Especially the invention relates to methods for the use of mutant subtilisins in organic solvents for the catalysis of reactions involving ester formation and cleavage, including acylations and deacylations, and amidations and deamidations. The methods provide novel strategies which are useful in the synthesis of deoxynucleosides, dideoxynucleosides, peptides, sugars and the like.
    Type: Grant
    Filed: January 26, 1989
    Date of Patent: May 26, 1992
    Assignee: Genex Corporation
    Inventors: Philip N. Bryan, Michael W. Pantoliano, Michele L. Rollence, Chi H. Wong
  • Patent number: 5013657
    Abstract: The invention relates to subtilisin enzymes which have been modified by mutating a nucleotide sequence (gene) coding for the subtilisin. The modified subtilisin enzymes have enhanced thermal stability.
    Type: Grant
    Filed: April 12, 1988
    Date of Patent: May 7, 1991
    Inventors: Philip N. Bryan, Michael W. Pantoliano
  • Patent number: 4990452
    Abstract: The invention relates to modified subtilisin enzymes which have increased thermal stability. The modified subtilisin enzymes have at least two or more amino acid mutations which confer increased thermal stability. It has been discovered that combining individual stabilizing mutations in subtilisin frequently results in an additive increase in thermal stability. In addition, the invention pertains to cloned mutant genes coding for a subtilisin material having at least two amino acid substitution which has increased thermal stability.
    Type: Grant
    Filed: April 12, 1988
    Date of Patent: February 5, 1991
    Assignee: Genex Corporation
    Inventors: Philip N. Bryan, Michael W. Pantoliano
  • Patent number: 4980288
    Abstract: Cloned DNA is mutated by creating a single-stranded target region in a cloned DNA segment, and introducing a mutation into the single-stranded target region by treating the target region with a chemical or biological mutagenizing agent capable of introducing mutations into single-stranded DNA. The mutated target region then is rendered double-stranded and a microorganism is transformed with the mutated double-stranded DNA present in an expression vector. The transformed microorganism is cultivated under conditions wherein the mutated DNA is expressed to form an expression product, and the expression product is screened to identify a desired mutation in the DNA segment. Mutant subtilisins of enhanced thermal stability are also disclosed.
    Type: Grant
    Filed: December 14, 1987
    Date of Patent: December 25, 1990
    Assignee: Genex Corporation
    Inventors: Philip N. Bryan, Michele L. Rollence, Michael W. Pantoliano